Announced Thu, 13 Aug · 14:50 IST
FY27 guidance raised; CAR-T, UK sub, energy demerger planned
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-7.1%1-day move
₹93.48
prior close
₹90.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.6—-0.6+0.4-7.1-8.0-9.7-7.1-10.1—————
Up moveDown movePending
AI summary
FY27 guidance: revenue at least Rs 1,550 crore (20%+ growth), PAT at least Rs 178 crore (50%+ growth). Plans demerger of renewable energy and LED arm into Lords Shakti Power (60% holding). Exclusive India CAR-T therapy deal for 5 centres in Mumbai and Bangalore by March 2027. UK and Swiss subsidiaries set up for IVD exports. New Lords Mark Medicine for tier-2 oncology hospitals, plus 50 dialysis centres by March 2027. ICMR approval for OneDNA genomic test.
Likely market impact
Major healthcare expansion with explicit FY27 guidance; energy demerger may unlock separate valuation while new verticals add long-term optionality.